Lars Åke Gunnar Hallman
Director/Board Member at R-Klinik Oy
Network origin in Lars Åke Gunnar Hallman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.
5
| Subsidiary | Biotechnology | 5 |
Unimedic AB
 Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Akademikliniken HJ AB
 Akademikliniken HJ AB Medical/Nursing ServicesHealth Services Akademikliniken HJ AB engages in aesthetic and reconstructive plastic surgery, aesthetic treatments, and medical care. Its activities cover a range of different plastic surgery procedures and micro surgical procedures. The firm offers dentistry; reconstructive surgery; skin, facial, and body procedures; and skin care products. The company was founded by Per Göran Hedén and Jan Urban Jernbeck in 1991 and is headquartered in Stockholm, Sweden.
1
| Subsidiary | Medical/Nursing Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lars Åke Gunnar Hallman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| VALNEVA | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO General Counsel | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Valneva USA, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer | ||
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chief Executive Officer Public Communications Contact | |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member President Director/Board Member | |
| Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
| University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree | |
| Intercell Austria AG | Corporate Officer/Principal Chief Executive Officer | ||
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDCAP AB | Medical Specialties | Chairman Chairman | |
| SENSORION | Pharmaceuticals: Major | Director of Finance/CFO | |
| Atlantic Biotherapies | Chief Executive Officer | ||
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
| Chengdu Grimaud Breeding Co. Ltd. | Director/Board Member | ||
| Grimaud Deyang Animal Co. Ltd. | Director/Board Member | ||
| Vivalis Toyama Japan KK | Chairman | ||
| Smol Therapeutics SAS | Chief Executive Officer | ||
| University of Ottawa | College/University | Masters Business Admin | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
ACM Biolabs Pte Ltd.
 ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
EnteroBiotix Ltd.
 EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Director/Board Member | |
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Chemicals: Specialty | Director/Board Member | |
Synpromics Agbiosub Ltd.
 Synpromics Agbiosub Ltd. Miscellaneous Commercial ServicesCommercial Services Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| Agprome Ltd. | Director/Board Member | ||
Ambicare Health Ltd.
 Ambicare Health Ltd. Medical SpecialtiesHealth Technology Ambicare Health Ltd. manufactures medical products for skin care. The firm develops and commercializes proprietary, light emitting diode (LED) based devices for the treatment skin conditions and diseases. Its ambulatory lighting products offer solutions incorporating OLED (Organic Light Emitting Diode) and LED (Light Emitting Diode) technologies. The products offer battery operated flexible packaged solutions with high light uniformity. The company was founded by James Ferguson and Ifor Samuel in 2004 and is headquartered in Livingston, the United Kingdom. | Medical Specialties | Chairman | |
| Stuart & Muir Consulting Ltd. | Director/Board Member | ||
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Biotechnology | Chief Executive Officer | |
| University of Paisley | College/University | Undergraduate Degree | |
Glaxo Laboratories Ltd.
 Glaxo Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK. | Medical Distributors | Director of Finance/CFO | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
QSpine Ltd.
 QSpine Ltd. Medical SpecialtiesHealth Technology QSpine Ltd. designs, manufactures and distributes medical devices in the surgical spine market segment. Its products include Mobi-C, sterispine pedicle screw, sterispine lumber cage and spinetune and shivas cervical cage. The company was founded by Forbes Butterfield and Stuart Hunter Carmichael in 2011 and is headquartered in Corby, the United Kingdom. | Medical Specialties | Director/Board Member | |
Pays de la Loire Participations
 Pays de la Loire Participations Investment ManagersFinance Investissement pour le Développement des Entreprises l'Emploi is designed to invest in small and mid cap companies based in the Pays de la Loire region of France. The fund will invest mainly in innovative companies with a profitable track record and help them in their growth by taking minority participation. | Investment Managers | Director/Board Member | |
| University of Lund | College/University | Undergraduate Degree | |
| GLYCOREX TRANSPLANTATION AB | Medical Specialties | Director/Board Member | |
FrostPharma AB
 FrostPharma AB Pharmaceuticals: MajorHealth Technology FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch. | Pharmaceuticals: Major | Director/Board Member | |
| Prooxpharma AB | Director/Board Member | ||
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer |
Statistics
International
| United Kingdom | 17 |
| Sweden | 12 |
| France | 7 |
| Austria | 5 |
| United States | 4 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 107 |
| Chairman | 36 |
| Chief Executive Officer | 29 |
| Corporate Officer/Principal | 28 |
| Director of Finance/CFO | 12 |
Most connected contacts
- Stock Market
- Insiders
- Lars Åke Gunnar Hallman
- Company connections
